Overexpression of Glucose Transporter-1 (GLUT-1) Predicts Poor Prognosis in Epithelial Ovarian Cancer

被引：67

作者：

Cho, Hanbyoul ^{[1
]}

Lee, You Sun ^{[1
]}

Kim, Julie ^{[1
,2
]}

Chung, Joon-Yong ^{[2
]}

Kim, Jae-Hoon ^{[1
]}

机构：

[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Obstet & Gynecol, Seoul 135720, South Korea

[2] NCI, Appl Mol Pathol Lab, Pathol Lab, NIH, Bethesda, MD 20892 USA

来源：

CANCER INVESTIGATION | 2013年 / 31卷 / 09期

基金：

新加坡国家研究基金会;

关键词：

GLUT-1; Ovarian cancer; Microarray; Biomarker; Immunohistochemistry; GLUCOSE-TRANSPORTER; EXPRESSION; CARCINOMA; SURVIVAL; ANGIOGENESIS; CELLS;

D O I：

10.3109/07357907.2013.849722

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Illumina microarray was used to identify differentially expressed genes in three epithelial ovarian cancer (EOC) cells. To validate themicroarray data, mRNA and protein level of glucose transporter-1 (GLUT-1) was examined. GLUT-1 had an EOC/normal cells ratio of 5.51 based on microarray. Real-time PCR and immunohistochemistry demonstrated that GLUT-1 expression was significantly increased in EOC (p=.029 and p<.001, respectively). On survival analysis, GLUT-1 overexpression (HR= 4.80, p=.027) and lymph nodemetastases (HR= 8.35, p=.016) conferred a significantly worse overall survival. In conclusion, GLUT-1 expression is remarkably upregulated in EOC and predicts a poor overall survival.

引用

页码：607 / 615

页数：9

共 50 条

[21] GLUT-1 glucose transporter: A marker of neoplastic progression in colonic epithelial neoplasms
Burstein, D
Rathan, A
Weiser, K
Pritsker, A
Itzkowitz, S
Haber, R
LABORATORY INVESTIGATION, 1996, 74 (01) : 308 - 308
[22] Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary
Cantuaria, G
Magalhaes, A
Penalver, M
Angioli, R
Braunschweiger, P
Gomez-Marin, O
Kanhoush, R
Gomez-Fernandez, C
Nadji, M
GYNECOLOGIC ONCOLOGY, 2000, 79 (01) : 33 - 37
[23] FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer
Liu, Longyang
Yi, Juanjuan
Yuan, Jianhuan
Yao, Tingting
Lin, Zhongqiu
Ning, Yingxia
Zeng, Zhaoyang
CANCER BIOMARKERS, 2020, 28 (01) : 1 - 8
[24] Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer
Hou, Teng
Yang, Chenlu
Tong, Chongjie
Zhang, Huiting
Xiao, Juan
Li, Jundong
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (01): : 280 - 287
[25] Glucose transporter 1 (GLUT-1) in human skeletal muscle
Schroeder, HD
Gaster, M
Handberg, A
Beck-Nielsen, H
DIABETES, 1999, 48 : A290 - A291
[26] GLUT-1 and its regulating factor HIF-1α expression in epithelial ovarian tumors: GLUT-1 is associated with molecular typing and grade of epithelial ovarian cancer
Yu, Xiu-Jie
Song, Jian-Chan
Du, Jing
Shi, Yi-Quan
Liu, Yi-Xin
Shen, Yan
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (04): : 4479 - 4487
[27] Glucose transporter-1 protein (GLUT-1) membranous expression is a marker of embryonal neoplasms of central nervous system
Giangaspero, F
Xu, X
Pession, A
Risi, V
Vortmeyer, A
Loda, M
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (05): : 193 - 193
[28] Overexpression of GLUT-1 glucose transporter in human malignant pancreatic tumors. Immunohistochemical study of GLUT-1, 2, 3, 4, and 5 glucose transporters
Higashi, T
Honda, T
Kimura, T
Magata, Y
Konishi, J
Ohshio, G
Hosotani, R
Imamura, M
Tamaki, N
GASTROENTEROLOGY, 1996, 110 (04) : A528 - A528
[29] The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients
Sadlecki, Pawel
Bodnar, Magdalena
Grabiec, Marek
Marszalek, Andrzej
Walentowicz, Pawel
Sokup, Alina
Zegarska, Jolanta
Walentowicz-Sadlecka, Malgorzata
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[30] The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV
Manel, N
Kim, FJ
Kinet, S
Taylor, N
Sitbon, M
Battini, JL
CELL, 2003, 115 (04) : 449 - 459

← 1 2 3 4 5 →